Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-04-05, Stock:ABBV, The news for the past five days is as follows:
2019-03-29: NEWS1: Can These Biotech Stocks Take On Arthritis Powerhouse AbbVie?.NEWS2: Wall Street is buzzing about Gilead’s rheumatoid arthritis drug. Here’s why.NEWS3: Attention Biotech Investors: Mark Your Calendar For These April PDUFA Dates.NEWS4: Pharma Stock Roundup: AZN Inks Cancer Deal, ABBV, NVS & Others Get Drug Approvals.NEWS5: Pharma Stock Roundup: AZN Inks Cancer Deal, ABBV, NVS & Others Get Drug Approvals.NEWS6: Can These Biotech Stocks Take On Arthritis Powerhouse AbbVie?.NEWS7: Gilead & Galapagos Announce Positive Data on Arthritis Drug.NEWS8: Gilead & Galapagos Announce Positive Data on Arthritis Drug.NEWS9: Analysts Raise Neurocrine Biosciences’ Target Price in March.
2019-04-01: NEWS1: AbbVie (ABBV) Gains But Lags Market: What You Should Know.NEWS2: Alector Initiates Phase 1 Trial of AL003 for the Treatment of Patients with Alzheimer’s Disease.
2019-04-02: NEWS1: Noteworthy Tuesday Option Activity: MO, RTN, ABBV.NEWS2: Noteworthy Tuesday Option Activity: MO, RTN, ABBV.NEWS3: 3 Healthcare Stocks to Trade Now.NEWS4: 3 Healthcare Stocks to Trade Now.NEWS5: Trump delays health care vote until after 2020 election.NEWS6: AbbVie Rises 3%.
2019-04-03: NEWS1: Alector (ALEC) Initiates Phase I Alzheimer's Study on AL003.NEWS2: Alector (ALEC) Initiates Phase I Alzheimer's Study on AL003.NEWS3: Notable ETF Outflow Detected - IWV, ABBV, MMM, HON.NEWS4: Notable ETF Outflow Detected - IWV, ABBV, MMM, HON.NEWS5: Alector (ALEC) Initiates Phase I Alzheimer's Study on AL003.NEWS6: AbbVie to Host First-Quarter 2019 Earnings Conference Call.
2019-04-04: NEWS1: 10 Medical Marijuana Stocks to Cure Your Portfolio.NEWS2: AbbVie Announces New Formulary Listings for its Hepatitis C Treatment MAVIRET™.NEWS3: Novartis Resubmits BLA to FDA for Biosimilar of Neulasta.

Answer: Rise